Diagnostic News and Research

RSS

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

The Family Heart Foundation, a leading research and advocacy organization, shared results from an analysis of its large U.S. Family Heart DatabaseTM showing significant disparities exist in the treatment of familial hypercholesterolemia (FH) among racial groups, and by income and education levels.

7 Nov 2022

Personalized whole genome sequencing approach could double the diagnostic rates of rare diseases

Tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases, finds a new study led by UCL researchers.

7 Nov 2022

Pioneering artificial intelligence could ease winter pressures on hospitals

Pioneering artificial intelligence (AI) which automatically diagnoses lung diseases – such as tuberculosis and pneumonia – could ease winter pressures on hospitals, University of the West of Scotland researchers believe.

7 Nov 2022

MGI Partners with Imperial College London to Establish Overseas Customer Experience Center in the UK

...

From MGI 7 Nov 2022

Llusern debuts Lodestar UTI molecular diagnostic platform at Medica 2022

UK diagnostics manufacturer, Llusern Scientific, will preview its Lodestar DX molecular platform at Medica 2022 in Dusseldorf (14-17 November).

From Llusern Scientific Ltd. 7 Nov 2022

New risk analysis strategy benefits chest pain patients compared to the usual testing approach

A study comparing two approaches for diagnosing heart disease found that a risk analysis strategy is superior to the usual approach of immediately performing functional tests or catheterization for low- to intermediate-risk patients with new-onset chest pain.

6 Nov 2022

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System.

From Beckman Coulter Life Sciences 4 Nov 2022

New evaluation data shows the clinical utility of SOPHiA DDM Dx HRD Solution

SOPHiA GENETICS, a cloud-native software company in the healthcare space, debuted new data at the European Society of Gynaecological Oncology (ESGO) Congress as part of a poster (#PA-065) presented by Prof. Alexandre Harlé of the Institut de Cancérologie de Lorraine, France.

3 Nov 2022

Researchers provide insights on how to overcome resistance in cancer therapy

The latest developmental drugs, particularly for the use in oncology, rely on the targeted degradation of harmful pathogenic proteins.

3 Nov 2022

Whole-genome sequencing is a more comprehensive prenatal test l BGI Perspectives

BGI-Research and the Maternal and Child Health Hospital of Hubei Province (MCHH) published whole-genome sequencing research results in npj Genomic Medicine.

From BGI Genomics 3 Nov 2022

Research reveals how whole-genome sequencing may enhance detection of fetal CNS anomalies

BGI-Research and the Maternal and Child Health Hospital of Hubei Province (MCHH) published whole-genome sequencing research results in npj Genomic Medicine.

3 Nov 2022

Study determines the diagnostic utility of liver stiffness measurement

Even after chronic hepatitis C has been cured, portal hypertension remains the major factor driving the development of complications in advanced liver disease. In cooperation with researchers from Spain, a research team led by Georg Semmler and Mattias Mandorfer from the Division of Gastroenterology and Hepatology at MedUni Vienna's Department of Medicine III showed that the non-invasive tests explored in their earlier studies accurately estimate the probability of sequelae.

3 Nov 2022

Contrastive learning model can detect lung damage in long-COVID patients

For patients dealing with lingering respiratory symptoms from the novel coronavirus, a chest X-ray can reveal only so much.

2 Nov 2022

The importance of accurate pipetting in biomedical laboratory work

In this interview, Stephanie Stursberg, Group Product Manager for pipetting platforms at INTEGRA Biosciences, talks to NewsMedical about the importance of accurate and efficient pipetting in biomedical laboratory work.

From INTEGRA Biosciences 2 Nov 2022

EULAR points-to-consider can guide diagnostic evaluation, treatment and monitoring of SAIDs

SAIDs are a group of multi-system disorders caused by dysfunction in the innate immune system. A number of these SAIDs are mediated by a cytokine called interleukin-1 (IL-1), including the cryopyrin-associated periodic syndromes (CAPS), tumor necrosis factor receptor-associated periodic syndrome (TRAPS), mevalonate kinase deficiency (MKD), and deficiency of the IL-1 receptor antagonist (DIRA).

1 Nov 2022

New approach increases the likelihood of detecting antiphospholipid syndrome

The Geneva University Hospitals, the University of Geneva and their spin-off Endotelix have created the best possible target molecule for the antibodies responsible for antiphospholipid syndrome.

1 Nov 2022

WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

WHO’s TAG-VE group presented the most recent evidence on Omicron evolution and genetic diversity.

1 Nov 2022

Novel computational method maps the architecture of human tissues in unprecedented detail

Weill Cornell Medicine researchers have developed a computational method to map the architecture of human tissues in unprecedented detail. Their approach promises to accelerate studies on organ-scale cellular interactions and could enable powerful new diagnostic strategies for a wide range of diseases.

1 Nov 2022

Researchers use deep neural networks to virtually stain microscopic images of unlabeled tissue

In the hospital, there is a group of doctors who use tissue samples as "evidence materials", analyze the evidence using knives, slicers and microscopes to extract clues from the tissue samples, and provide patients with "verdicts" - diagnostic reports.

31 Oct 2022

SARS-CoV-2 Omicron BA.2 less severe than Delta and original Omicron

Researchers estimate the severity of infection with the SARS-CoV-2 Omicron BA.2 subvariant as compared to that caused by the Delta and Omicron variants.

31 Oct 2022

Diagnostic News and Research

New analysis finds significant disparities in the treatment of familial hypercholesterolemia

Personalized whole genome sequencing approach could double the diagnostic rates of rare diseases

Pioneering artificial intelligence could ease winter pressures on hospitals

MGI Partners with Imperial College London to Establish Overseas Customer Experience Center in the UK

Llusern debuts Lodestar UTI molecular diagnostic platform at Medica 2022

New risk analysis strategy benefits chest pain patients compared to the usual testing approach

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

New evaluation data shows the clinical utility of SOPHiA DDM Dx HRD Solution

Researchers provide insights on how to overcome resistance in cancer therapy

Whole-genome sequencing is a more comprehensive prenatal test l BGI Perspectives

Research reveals how whole-genome sequencing may enhance detection of fetal CNS anomalies

Study determines the diagnostic utility of liver stiffness measurement

Contrastive learning model can detect lung damage in long-COVID patients

The importance of accurate pipetting in biomedical laboratory work

EULAR points-to-consider can guide diagnostic evaluation, treatment and monitoring of SAIDs

New approach increases the likelihood of detecting antiphospholipid syndrome

WHO’s TAG-VE group present the most recent evidence on Omicron sublineages BQ.1 and XBB

Novel computational method maps the architecture of human tissues in unprecedented detail

Researchers use deep neural networks to virtually stain microscopic images of unlabeled tissue

SARS-CoV-2 Omicron BA.2 less severe than Delta and original Omicron

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News